Lonza Group AG
LONN
Peringkat dalam Saham
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Harga Saham
$766.95
Kapitalisasi Pasar
$53.57B
Perubahan (1 hari)
1.35%
Perubahan (1 tahun)
9.01%
Negara
CH
Perdagangan Lonza Group AG (LONN)
Kategori
Healthcare
Jumlah saham beredar untuk Lonza Group AG (LONN)
Jumlah saham beredar per October 2026: 0
Menurut laporan keuangan terbaru dan harga saham Lonza Group AG, jumlah saham beredar saat ini adalah 0. Pada akhir October 2026, perusahaan memiliki 0 saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Lonza Group AG (LONN) dari 2004 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2025 | 70.02M | -1.68% |
| 2024 | 71.22M | -3.30% |
| 2023 | 73.65M | -0.78% |
| 2022 | 74.23M | -0.04% |
| 2021 | 74.26M | -0.20% |
| 2020 | 74.40M | 0.40% |
| 2019 | 74.11M | -0.40% |
| 2018 | 74.41M | 9.62% |
| 2017 | 67.88M | 28.40% |
| 2016 | 52.87M | 0.39% |
| 2015 | 52.66M | 0.91% |
| 2014 | 52.19M | 0.18% |
| 2013 | 52.10M | -6.80% |
| 2012 | 55.90M | 0.28% |
| 2011 | 55.74M | -1.48% |
| 2010 | 56.58M | 3.22% |
| 2009 | 54.81M | -3.69% |
| 2008 | 56.91M | -0.10% |
| 2007 | 56.97M | -3.42% |
| 2006 | 58.99M | 15.34% |
| 2005 | 51.15M | -0.01% |
| 2004 | 51.15M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| 0.00 | - |
BE
|
